Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review

June 2019 | 74 pages | ID: E5D61858624EN
GlobalData

Abstracts

Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, pharma central laboratory, biopharma product testing, genomic services, agro-science services, product testing, forensic services, environmental testing and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) services. Its analytical methods help in evaluating the safety, identity, composition, origin, authenticity and purity of biological products and substances. It harnesses its expertise in logistics and information technology to deliver a range of services. The company operates across Europe, North and South America, and Asia-Pacific. Eurofins is headquartered in Luxembourg.

Eurofins Scientific SE Key Recent Developments

Apr 26,2019: Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m
Mar 05,2019: Eurofins delivers solid FY 2018 results with revenues of EUR 3,781m and adjusted EBITDA of EUR 720m (19.0% of revenues), in line with its recently upgraded objectives
Nov 20,2018: Eurofins to distribute Synthego's industry-best genome engineering products in global channels
Oct 23,2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020 – Revenues objective for 2020 now set at EUR 5bn
Oct 02,2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Eurofins Scientific SE - Key Facts
Eurofins Scientific SE - Key Employees
Eurofins Scientific SE - Key Employee Biographies
Eurofins Scientific SE - Major Products and Services
Eurofins Scientific SE - History
Eurofins Scientific SE - Company Statement
Eurofins Scientific SE - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Eurofins Scientific SE - Business Description
Product Category: Agroscience Services
Overview
Product Category: Biopharma Services
Overview
Product Category: Clinical Diagnostics
Overview
Product Category: Consumer Product Testing
Overview
Product Category: Environmental Testing
Overview
Product Category: Food and Feed Testing
Overview
Product Category: Genomics Services
Overview
Product Category: REACH Services
Overview
Geographical Segment: Benelux
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Nordic Region
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: Total Western Europe
Performance
Geographical Segment: UK & Ireland
Performance
Eurofins Scientific SE - SWOT Analysis
SWOT Analysis - Overview
Eurofins Scientific SE - Strengths
Eurofins Scientific SE - Weaknesses
Eurofins Scientific SE - Opportunities
Eurofins Scientific SE - Threats
Eurofins Scientific SE - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Eurofins Scientific SE, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 26, 2019: Eurofins revenues grow 27% in Q1 2019 to EUR 1,067m
Mar 05, 2019: Eurofins delivers solid FY 2018 results with revenues of EUR 3,781m and adjusted EBITDA of EUR 720m (19.0% of revenues), in line with its recently upgraded objectives
Nov 20, 2018: Eurofins to distribute Synthego's industry-best genome engineering products in global channels
Oct 23, 2018: Eurofins posts strong revenue growth in Q3 2018 (EUR 955m, +30.6% yoy including over 5% organic growth) and raises its objectives for 2019-2020 – Revenues objective for 2020 now set at EUR 5bn
Oct 02, 2018: Eurofins BioPharma Product Testing Ireland opened the new extension in Dungarvan
Jul 31, 2018: Eurofins delivers strong revenue, profitability and cash flow growth in H1 2018
Jun 26, 2018: Eurofins raises its revenues objectives for 2018 to EUR 3.8bn (4bn pro-forma), to 4.3bn for 2019 and to 4.7bn for 2020
May 22, 2018: Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan
Apr 24, 2018: Eurofins revenues grow +23% in Q1 2018 to EUR 839m
Mar 06, 2018: Eurofins exceeds its recently-upgraded 2017 objectives on a strong growth momentum and raises its objectives for 2018

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Eurofins Scientific SE, Key Facts
Eurofins Scientific SE, Key Employees
Eurofins Scientific SE, Key Employee Biographies
Eurofins Scientific SE, Major Products and Services
Eurofins Scientific SE, History
Eurofins Scientific SE, Subsidiaries
Eurofins Scientific SE, Key Competitors
Eurofins Scientific SE, Ratios based on current share price
Eurofins Scientific SE, Annual Ratios
Eurofins Scientific SE, Annual Ratios (Cont...1)
Eurofins Scientific SE, Annual Ratios (Cont...2)
Eurofins Scientific SE, Interim Ratios
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Eurofins Scientific SE, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Eurofins Scientific SE, Performance Chart (2014 - 2018)
Eurofins Scientific SE, Ratio Charts
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Eurofins Scientific SE, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

SGS SA
R-Biopharm AG
Intertek Group Plc
Bureau Veritas SA
bioMerieux SA